Luis Brieva Ruiz

Solari, A; Montalban, X; Lechner-Scott, J; Piehl, F; Brochet, B; Langdon, D; Hupperts, R; Selmaj, K; Havrdova, EK; Patti, F; Brieva, L; Maida, EM; Alexandri, N; Smyk, A; Nolting, A; Keller, B

Improvements in quality of life over 2 years in patients treated with cladribine tablets for highly active relapsing multiple sclerosis: Final analysis of CLARIFY-MS

MULTIPLE SCLEROSIS JOURNAL 28 203-204. 01/10/2022.

Martín-Aguilar L.; Presas-Rodriguez S.; Rovira À.; Capellades J.; Massuet-Vilamajó A.; Ramió-Torrentà L.; Tintoré M.; Brieva-Ruiz L.; Moral E.; Cano-Orgaz A.; Blanco Y.; Batlle-Nadal J.; Carmona O.; Gea M.; Hervás-García J.V.; Ramo-Tello C.

Gadolinium-enhanced brain lesions in multiple sclerosis relapse

NEUROLOGIA 37 557-563. 01/09/2022.

[doi:10.1016/j.nrl.2021.10.005]

Castillo-Trivino, Tamara; Gomez-Ballesteros, Rocio; Borges, Monica; Martin-Martinez, Jesus; Sotoca, Javier; Alonso, Ana; Caminero, Ana B.; Borrega, Laura; Sanchez-Menoyo, Jose L.; Barrero-Hernandez, Francisco J.; Calles, Carmen; Brieva, Luis; Blasco-Quilez, Maria R.; Garcia-Soto, Julio Dotor; del Campo-Amigo, Maria; Navarro-Canto, Laura; Aguera, Eduardo; Garces-Redondo, Moises; Carmona, Olga; Gabaldon-Torres, Laura; Forero, Lucia; Hervas, Mariona; Mauriño J; Sainz de la Maza S

Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosis.

Multiple Sclerosis and Related Disorders 64 103969-103969. 01/08/2022.

[doi:10.1016/j.msard.2022.103969]

Gonzalez-Mingot, C; Lopez-Ortega, R; Brieva-Ruiz, L

The efficacy of combining topiramate and 4-aminopyridine to reduce relapses and interictal progression in two cases of episodic ataxia type 2

NEUROLOGICAL SCIENCES 43 5099-5101. 01/08/2022.

[doi:10.1007/s10072-022-06144-2]

Brieva, L; Estruch, BC; Merino JAG; Meca-Lallana, V; Rio, J; Rodriguez-Antigueedad, A; Aguera, E; Ara, JR; Luque, AA; Garcia, CA; Blanco, Y; Castillo-Trivino, T; Costa-Frossard, L; González Platas M; Pascual, LL; Llaneza-Gonzalez, M; Ginés MLM; Matias-Guiu, J; Meca-Lallana, JE; Bilbao, MM; Sempere, AP; Romero-Pinel, L; Saiz, A; Moral, E

Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology.

Multiple Sclerosis and Related Disorders 63 103805-103805. 01/07/2022.

[doi:10.1016/j.msard.2022.103805]

Vermersch P; Brieva-Ruiz L; Fox RJ; Paul F; Ramio-Torrenta L; Schwab M; Moussy A; Mansfield C; Hermine O; Maciejowski M

Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial.

Neurology-Neuroimmunology & Neuroinflammation 9 -. 01/05/2022.

[doi:10.1212/NXI.0000000000001148]

Sancho-Saldana, A; Gil Sánchez A; Quirant-Sanchez, B; Nogueras, L; Peralta, S; Solana, MJ; Gonzalez-Mingot, C; Gallego, Y; Quibus, L; Ramo-Tello, C; Presas-Rodriguez, S; Martinez-Caceres, E; Torres, P; Hervas, JV; Valls, J; Brieva, L

Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies.

Journal of Clinical Medicine 11 -. 29/04/2022.

[doi:10.3390/jcm11092509]

Fernández-Velasco JI; Monreal E; Kuhle J; Meca-Lallana V; Meca-Lallana J; Izquierdo G; Oreja-Guevara C; Gascón-Giménez F; Sainz de la Maza S; Walo-Delgado PE; Lapuente-Suanzes P; Maceski A; Rodríguez-Martín E; Roldán E; Villarrubia N; Saiz A; Blanco Y; Diaz-Pérez C; Valero-López G; Diaz-Diaz J; Aladro Y; Brieva L; Íñiguez C; González-Suárez I; Rodríguez de Antonio LA; García-Domínguez JM; Sabin J; Llufriu S; Masjuan J; Costa-Frossard L; Villar LM

Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology.

Frontiers in Immunology 13 842354-842354. 21/03/2022.

[doi:10.3389/fimmu.2022.842354]

Sainz de la Maza S; Maurino J; Borges M; Martín-Martínez J; Sotoca J; Alonso A; Caminero AB; Borrega L; Sánchez-Menoyo JL; Barrero-Hernández FJ; Calles C; Brieva L; Blasco MR; García-Soto JD; Campo-Amigo MD; Navarro-Cantó L; Agüera E; Garcés M; Carmona O; Gabaldón-Torres L; Forero L; Hervás M; de Alda LR; Gómez-Ballesteros R; Castillo-Triviño T

Measuring productivity loss in early relapsing-remitting multiple sclerosis.

Multiple Sclerosis and Related Disorders 58 103398-103398. 01/02/2022.

[doi:10.1016/j.msard.2021.103398]

Ramo-Tello C; Blanco Y; Brieva L; Casanova B; Martínez-Cáceres E; Ontaneda D; Ramió-Torrentá L; Rovira À

Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses.

Journal of Personalized Medicine 12 -. 22/12/2021.

[doi:10.3390/jpm12010006]

Munoz-Lopetegi, A; Pujol, M; Gimenez, M; Gaig, C; Brieva, L; Santamaria, J

Abnormal sleep behavior caused by hypoglycemia

SLEEP MEDICINE 85 268-270. 01/09/2021.

[doi:10.1016/j.sleep.2021.07.029]

Meca-Lallana, J; Garcia-Merino, JA; Martinez-Yelamos, S; Vidal-Jordana, A; Costa, L; Eichau, S; Rovira À; Brieva, L; Aguera, E; Zarranz, ARA

Identification of patients with relapsing multiple sclerosis eligible for high-efficacy therapies.

Neurodegenerative Disease Management 11 251-261. 01/06/2021.

[doi:10.2217/nmt-2020-0049]